tiprankstipranks
Trending News
More News >
Vera Therapeutics (VERA)
NASDAQ:VERA
US Market

Vera Therapeutics (VERA) Income Statement

Compare
751 Followers

Vera Therapeutics Income Statement

Last quarter (Q3 2025), Vera Therapeutics's total revenue was $―, a decrease of ― from the same quarter last year. In Q3, Vera Therapeutics's net income was $-80.29M. See Vera Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 846.00K$ 0.00$ -251.00K
Operating Expenses
$ 167.17M$ 102.01M$ 91.75M$ 34.40M$ 47.81M
Depreciation and Amortization
$ 105.00K$ 21.00K$ -846.00K$ 176.00K$ 251.00K
EBITDA
$ -144.42M$ -92.18M$ -88.91M$ -32.41M$ -52.99M
Operating Income
$ -167.17M$ -102.01M$ -90.90M$ -34.40M$ -48.06M
Other Income/Expenses
$ 15.02M$ 6.02M$ 1.85M$ 1.79M$ -5.35M
Pretax Income
$ -152.15M$ -95.99M$ -89.06M$ -32.61M$ -53.41M
Net Income
$ -152.15M$ -95.99M$ -89.06M$ -32.61M$ -53.41M
Per Share Metrics
Basic EPS
$ -2.75$ -2.25$ -3.35$ -2.43$ -14.40
Diluted EPS
$ -2.75$ -2.25$ -3.35$ -2.43$ -14.40
Weighted Average Shares Outstanding
55.33M 42.71M 26.57M 13.44M 3.71M
Weighted Average Shares Outstanding (Diluted)
55.33M 42.71M 26.57M 13.44M 3.71M
Currency in USD

Vera Therapeutics Earnings and Revenue History